| Symbol: |
CECR5
|
| Description: |
cat eye syndrome chromosome region, candidate 5 [Source:HGNC Symbol;Acc:1843]
|
| Location: |
Chr22:17618401-17646177[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:440
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| CECR5 |
3-Deazaneplanocin, hydrochloride |
0.037 |
Down |
| CECR5 |
Aspidospermin |
0.019 |
Down |
| CECR5 |
2H-1-Benzopyran, 6-methoxy-3-nitro-2-[2,2,2',2'-tetramethyl (4,4'-bi-1,3-dioxolan)-5-yl]- |
0.003 |
Down |
| CECR5 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.001 |
Up |
| CECR5 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.004 |
Up |
| CECR5 |
NSC 62349 |
0.018 |
Up |
| CECR5 |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.025 |
Down |
| CECR5 |
NSC 6246 |
0.046 |
Down |
| CECR5 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride |
0.042 |
Down |
| CECR5 |
Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- |
0.001 |
Down |
| CECR5 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.001 |
Up |
| CECR5 |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.018 |
Down |
| CECR5 |
Naphtho[2,3-d]thiazole-4,9-dione, 2-[(4-nitrophenyl) amino]- |
0.045 |
Down |
| CECR5 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.006 |
Up |
| CECR5 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.046 |
Up |
Expression pattern: Sensitivity / Resistance
Total:30 Current:7
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:6
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
| miRNA:
~ Export ~
|
Records:96
Total:7 Current:1
[First] [Prev]  Next Last 
|